DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
77.98
+5.25 (7.22%)
At close: Jul 16, 2026, 4:00 PM EDT
77.94
-0.04 (-0.05%)
Pre-market: Jul 17, 2026, 6:31 AM EDT
DexCom Employees
DexCom had 11,100 employees as of December 31, 2025. The number of employees increased by 800 or 7.77% compared to the previous year.
Employees
11,100
Change (1Y)
800
Growth (1Y)
7.77%
Revenue / Employee
$434,045
Profits / Employee
$83,820
Market Cap
30.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,100 | 800 | 7.77% |
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| Boston Scientific | 59,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Edwards Lifesciences | 16,000 |
| Globus Medical | 6,000 |
DXCM News
- 20 hours ago - DexCom price target raised to $87 from $80 at Truist - TheFly
- 1 day ago - DexCom price target raised to $90 from $85 at Mizuho - TheFly
- 3 days ago - DexCom announces Health Canada authorization for Dexcom G7 15 Day CGM - TheFly
- 3 days ago - Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Business Wire
- 7 days ago - Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time - Business Wire
- 13 days ago - Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 23 days ago - DexCom initiated with a Buy at Deutsche Bank - TheFly
- 23 days ago - DexCom announces milestones to make glucose biosensing more accessible - TheFly